Genmab Reports Q2 DARZALEX Net Sales Of $4.207B, Up 17.6% YoY
Genmab Reports Q2 DARZALEX Net Sales Of $4.207B, Up 17.6% YoY
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day